Workforce challenges to implementation of myopia management in Europe: an electronic/telephone expert survey
{{output}}
The European Medicines Agency and the UK Medicines and Healthcare products Regulatory Agency recently approved the first commercial preparation of low-concentration atropine, Ryjunea, for use in children aged 3 years and older to slow the progression of myopia... ...
